Lerner SP - Search Results

1

Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens.

Tokunaga H, Shariat SF, Green AE, Brown RM, Zhou JH, Benedict WF, Lerner SP. Tokunaga H, et al. Among authors: lerner sp. Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):16-22. doi: 10.1016/s0360-3016(01)01586-3. Int J Radiat Oncol Biol Phys. 2001. PMID: 11516846

2

Radical cystectomy in regionally advanced bladder cancer.

Lerner SP, Skinner E, Skinner DG. Lerner SP, et al. Urol Clin North Am. 1992 Nov;19(4):713-23. Urol Clin North Am. 1992. PMID: 1279876 Review.

3

Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology.

Ohori M, Abbas F, Wheeler TM, Kattan MW, Scardino PT, Lerner SP. Ohori M, et al. Among authors: lerner sp. J Urol. 1999 Feb;161(2):500-4. J Urol. 1999. PMID: 9915435

4

Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer.

Benedict WF, Lerner SP, Zhou J, Shen X, Tokunaga H, Czerniak B. Benedict WF, et al. Among authors: lerner sp. Oncogene. 1999 Feb 4;18(5):1197-203. doi: 10.1038/sj.onc.1202452. Oncogene. 1999. PMID: 10022125

5

The loss of expression of transforming growth factor-beta receptors correlates with the histopathologic tumor grade in bladder transitional cell carcinoma patients.

Lee DH, Yang SC, Hong SJ, Chung BH, Chung HJ, Tokunaga H, Kim IY, Song YS, Lerner SP, Morton RA Jr. Lee DH, et al. Among authors: lerner sp. Yonsei Med J. 1999 Apr;40(2):118-23. doi: 10.3349/ymj.1999.40.2.118. Yonsei Med J. 1999. PMID: 10333714 Free article.

6

Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients.

Tokunaga H, Lee DH, Kim IY, Wheeler TM, Lerner SP. Tokunaga H, et al. Among authors: lerner sp. Clin Cancer Res. 1999 Sep;5(9):2520-5. Clin Cancer Res. 1999. PMID: 10499628

7

Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.

Shariat SF, Weizer AZ, Green A, Laucirica R, Frolov A, Wheeler TM, Lerner SP. Shariat SF, et al. Among authors: lerner sp. Urology. 2000 Nov 1;56(5):735-40. doi: 10.1016/s0090-4295(00)00756-1. Urology. 2000. PMID: 11068290

8

E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder.

Shariat SF, Pahlavan S, Baseman AG, Brown RM, Green AE, Wheeler TM, Lerner SP. Shariat SF, et al. Among authors: lerner sp. Urology. 2001 Jan;57(1):60-5. doi: 10.1016/s0090-4295(00)00892-x. Urology. 2001. PMID: 11164145

9

Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival.

Younes M, Juarez D, Lechago LV, Lerner SP. Younes M, et al. Among authors: lerner sp. Anticancer Res. 2001 Jan-Feb;21(1B):575-8. Anticancer Res. 2001. PMID: 11299807

10

E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.

Byrne RR, Shariat SF, Brown R, Kattan MW, Morton RA JR, Wheeler TM, Lerner SP. Byrne RR, et al. Among authors: lerner sp. J Urol. 2001 May;165(5):1473-9. J Urol. 2001. PMID: 11342899

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters